JPH0239256Y2 - - Google Patents
Info
- Publication number
- JPH0239256Y2 JPH0239256Y2 JP2632688U JP2632688U JPH0239256Y2 JP H0239256 Y2 JPH0239256 Y2 JP H0239256Y2 JP 2632688 U JP2632688 U JP 2632688U JP 2632688 U JP2632688 U JP 2632688U JP H0239256 Y2 JPH0239256 Y2 JP H0239256Y2
- Authority
- JP
- Japan
- Prior art keywords
- film
- base material
- adhesive layer
- test
- dark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000012360 testing method Methods 0.000 claims description 21
- 239000000463 material Substances 0.000 claims description 13
- 239000012790 adhesive layer Substances 0.000 claims description 12
- 229920003002 synthetic resin Polymers 0.000 claims description 7
- 239000000057 synthetic resin Substances 0.000 claims description 7
- 230000004520 agglutination Effects 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000009600 syphilis test Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
【考案の詳細な説明】
本考案は免疫反応を用いる検査に使用される臨
床検査具に存する。[Detailed Description of the Invention] The present invention resides in a clinical test tool used for tests using immune reactions.
従来、赤血球、カーボン、ラテツクス等を担体
としてこれに抗体又は抗原を感作した試薬と、検
体血清中の抗原又は抗体との反応により前記担体
に凝集を生じさせ、その凝集度合により判定を行
うことが臨床検査分野において一般に行なわれて
いる。このような凝集度合の判定には、透明ガラ
ス板の表面を黒色に着色し、ガラス板上の使用箇
所に適宜円形、惰円形等の輪環を印刷したもの、
厚手の紙に同様の輪環を印刷したもの等が使用さ
れている。 Conventionally, a reagent using red blood cells, carbon, latex, etc. as a carrier and sensitized with antibodies or antigens is reacted with the antigen or antibody in the sample serum to cause agglutination in the carrier, and determination is made based on the degree of agglutination. is commonly performed in the field of clinical testing. To determine the degree of agglomeration, the surface of a transparent glass plate is colored black, and a circular ring, a circular ring, etc. is printed on the glass plate as appropriate at the location where it is used.
Thick paper with a similar ring printed on it is used.
しかしながらガラス板を用いた場合は、輪環を
入れる印刷作業が行ないにくいし、検査量が多い
場合は多数のガラス板を使用する必要があり、コ
ストが高くつく欠点があつた。 However, when a glass plate is used, it is difficult to carry out the printing process to insert the ring, and when a large amount of inspection is required, it is necessary to use a large number of glass plates, resulting in high costs.
又厚手の紙を使用したものでは、検体血清を滴
下した際に吸収しやすく、拡がりが悪くなるので
凝集度合の判定を誤つてしまうおそれがあつた。 In addition, if thick paper is used, when the sample serum is dropped, it is easily absorbed and spreads poorly, so there is a risk of erroneously determining the degree of agglutination.
本考案は上記欠点を解消することを目的とする
ものであり、その要旨は、暗色調の基材１の表面
に透明もしくは半透明の合成樹脂フイルム２が多
数枚重ね合わされ、該フイルム２は裏面に形成さ
れた粘着剤層４により取剥し可能に貼着されてい
る、臨床検査具に存する。 The purpose of the present invention is to eliminate the above-mentioned drawbacks, and its gist is that a large number of transparent or translucent synthetic resin films 2 are superimposed on the surface of a dark-colored base material 1, and the film 2 has a reverse side. The clinical test device is removably affixed by an adhesive layer 4 formed on the substrate.
次に本考案臨床検査具の一例について更に詳細
に説明する。 Next, an example of the clinical testing device of the present invention will be explained in more detail.
１は基材であり、例えば紙、合成樹脂、金属、
木材等からなり、黒色、灰色、暗青色、暗褐色、
暗柴色等の暗色調が付されている。２は透明又は
半透明の合成樹脂フイルムであり、例えばポリス
チレン系、ポリオレフイン系、ポリ塩化ビニル
系、ポリアミド系、ポリエステル系、ポリカーボ
ネート系、ポリビニルアルコール系、ポリアクリ
ル酸エステル系、セルロース誘導体系等の単独重
合体、共重合体、及びこれらの重合体の混合体等
が使用される。該フイルム２が合成樹脂であるの
は、凝集反応を行なわせる際に検体血清を吸収し
ないので凝集像の拡がりが得られるからである。
又透明もしくは半透明とされるのは、基材の暗色
調が透けて見えるために凝集像の確認がしやすく
なるからである。 1 is a base material, such as paper, synthetic resin, metal,
Made of wood, etc., available in black, gray, dark blue, dark brown,
It has a dark color tone such as dark shiroba color. 2 is a transparent or translucent synthetic resin film, such as polystyrene, polyolefin, polyvinyl chloride, polyamide, polyester, polycarbonate, polyvinyl alcohol, polyacrylic ester, cellulose derivative, etc. Polymers, copolymers, mixtures of these polymers, etc. are used. The reason why the film 2 is made of synthetic resin is that it does not absorb the sample serum during the agglutination reaction, so that a spread out agglutination image can be obtained.
The reason why it is transparent or semi-transparent is that the dark tone of the base material can be seen through, making it easier to confirm the aggregated image.
該フイルム２の表面には、検査箇所を指定する
ために円形又は惰円形の輪環３が印刷されてい
る。輪環３は通常一枚のフイルム２に５個程度印
刷される。前記フイルム２の厚みは、機械的強度
を有する必要があると共に多数枚重ね合わせられ
た際にもかさばらないものとし、しかも順次フイ
ルム２を取剥してゆく点を考慮して30〜100μｍ
程度とされるのが好適である。 A circular or circular ring 3 is printed on the surface of the film 2 to designate the inspection location. Usually, about five rings 3 are printed on one sheet of film 2. The thickness of the film 2 must be 30 to 100 μm, as it needs to have mechanical strength and not be bulky even when a large number of films are stacked together, and in consideration of the fact that the film 2 is to be peeled off one after another.
It is preferable that it be about a certain degree.
該フイルム２は把持部５を除く裏面全体、又は
その側縁部に形成された粘着剤層４により基材１
の側縁部に取剥し可能に貼着される。フイルム２
の粘着剤層４はその片側の側縁部において形成さ
れているが、粘着剤層４の厚みは10〜35μｍ程度
とされるのが好適である。 The film 2 is attached to the base material 1 by an adhesive layer 4 formed on the entire back surface excluding the grip portion 5 or on the side edges thereof.
It is removably attached to the side edge of the film 2
The adhesive layer 4 is formed on one side edge of the adhesive layer 4, and the thickness of the adhesive layer 4 is preferably about 10 to 35 μm.
これは粘着剤層４の厚みが大きすぎると、貼着
されたフイルム２の位置ずれを生じたり、フイル
ム２を取剥す際の粘着剤の残りを発生するおそれ
があり、又把持部５を除く裏面全体に粘着剤層４
が形成される場合は粘着剤層４が基材２の暗色調
の透視を妨げることになるからである。前記フイ
ルム２は基材１の側縁部に沿つて通常は10枚程度
を重ね合わせて貼着される。 This is because if the thickness of the adhesive layer 4 is too large, there is a risk that the attached film 2 may be misaligned, adhesive may remain when the film 2 is removed, and the grip portion 5 may be removed. Adhesive layer 4 on the entire back side
This is because, if the adhesive layer 4 is formed, the adhesive layer 4 will prevent the dark color of the base material 2 from being seen through. The films 2 are usually pasted along the side edges of the base material 1 in a stack of about 10 films.
尚前記フイルム２は短冊状に分割されたものが
並設されていてもよい。前記フイルム２の基材１
の側縁部に沿つて貼着されない方の縁部は基材１
よりも外側に延設されており、上方のフイルム２
を取剥すに際し作業をしやすくするための把持部
５として使用される。 The film 2 may be divided into strips and arranged side by side. Base material 1 of the film 2
The edge that is not pasted along the side edge of the base material 1
The upper film 2
It is used as a grip part 5 to facilitate the work when removing.
本考案臨床検査具によれば、上側のフイルム２
上で抗原と抗体との凝集反応を利用した臨床検査
を行なつた後、このフイルム２を取剥し、下側の
フイルム２を同様に使用して検査を行ない、多量
の検体の検査を同じ基材１上のフイルム２を順次
使用することにより行なうことができる。本考案
臨床検査具は、Ｃ−反応性蛋白（CRP）試験、
抗ストレプトリジン・Ｏ（ASLO）試験、リウマ
チ因子（RA）試験、抗核抗体（LE）試験、梅毒
検査、甲状線自己抗体（TA）試験、ABO式血液
型判定試験、Rh式血液型検査、血液の交差適合
試験、免疫グロブリン（IgG，Ａ，Ｍ，Ｄ）測定
試験等に使用して好適である。 According to the clinical test device of the present invention, the upper film 2
After performing a clinical test using the agglutination reaction between antigen and antibody as shown above, this film 2 is removed and the test is performed using the lower film 2 in the same manner, allowing a large number of specimens to be tested using the same basis. This can be done by sequentially using the film 2 on the material 1. The clinical test device of this invention is a C-reactive protein (CRP) test,
Anti-streptolysin O (ASLO) test, rheumatoid factor (RA) test, antinuclear antibody (LE) test, syphilis test, thyroid autoantibody (TA) test, ABO blood grouping test, Rh blood grouping test, It is suitable for use in blood cross-matching tests, immunoglobulin (IgG, A, M, D) measurement tests, etc.
実施例 １
厚さ0.5mmの黒色合成樹脂板上に、厚さ30μｍの
透明ポリエチレン延伸フイルムであつて輪環を面
上に５箇ずつ印刷したものを10枚重ね合わせ、側
縁部の厚さ20μｍに粘着剤が塗布されて形成され
た面を利用し夫々基材の側縁部において貼着し
た。このようにして得られた臨床検査具を使用し
てポリスチレンラテツクスに抗体を感作したRA
ラテツクス試薬を0.05mlを輪環内に落とし、RA
陽性コントロール血清を用い凝集度を判定した。
この際の凝集像の判定は、フイルムを通して基材
の暗色調が透過できるため明確に行ない得た。Example 1 Ten sheets of transparent polyethylene stretched film with a thickness of 30 μm with five rings printed on each surface were stacked on a black synthetic resin plate with a thickness of 0.5 mm, and the thickness of the side edges was The adhesive was applied to a thickness of 20 μm, and the adhesive was applied to the side edges of each base material. RA sensitized with antibodies to polystyrene latex using the clinical test device obtained in this way
Drop 0.05ml of latex reagent into the ring and RA
The degree of agglutination was determined using a positive control serum.
At this time, the agglomerated image could be clearly judged because the dark tone of the base material could be transmitted through the film.
第１図は本考案臨床検査具の一例を示す平面
図、第２図は同上の裏面側縁部に粘着剤層が形成
された例を示す部分断面図、第３図は把持部を除
く裏面全体に粘着剤層が形成された例を示す部分
断面図である。
符号の説明、１…基材、２…合成樹脂フイル
ム、３…輪環、４…粘着面、５…把持部。
Fig. 1 is a plan view showing an example of the clinical testing device of the present invention, Fig. 2 is a partial sectional view showing an example in which an adhesive layer is formed on the side edge of the back side of the same, and Fig. 3 is the back side excluding the gripping part. FIG. 3 is a partial cross-sectional view showing an example in which an adhesive layer is formed on the entire surface. Explanation of the symbols: 1...Base material, 2...Synthetic resin film, 3...Ring, 4...Adhesive surface, 5...Gripping part.
Claims (1)
成樹脂フイルムが多数枚重ね合わされ、該フイル
ムは裏面に形成された粘着剤層により取剥し可能
に貼着されている、臨床検査具。 A clinical testing device in which a large number of transparent or translucent synthetic resin films are superimposed on the surface of a dark-colored base material, and the films are removably affixed with an adhesive layer formed on the back side.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2632688U JPH0239256Y2 (en) | 1988-02-29 | 1988-02-29 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2632688U JPH0239256Y2 (en) | 1988-02-29 | 1988-02-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63152559U JPS63152559U (en) | 1988-10-06 |
| JPH0239256Y2 true JPH0239256Y2 (en) | 1990-10-22 |
Family
ID=30827307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2632688U Expired JPH0239256Y2 (en) | 1988-02-29 | 1988-02-29 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0239256Y2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8909861B2 (en) | 2004-10-21 | 2014-12-09 | Microsoft Corporation | Using external memory devices to improve system performance |
| US9361183B2 (en) | 2008-09-19 | 2016-06-07 | Microsoft Technology Licensing, Llc | Aggregation of write traffic to a data store |
| US9529716B2 (en) | 2005-12-16 | 2016-12-27 | Microsoft Technology Licensing, Llc | Optimizing write and wear performance for a memory |
-
1988
- 1988-02-29 JP JP2632688U patent/JPH0239256Y2/ja not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8909861B2 (en) | 2004-10-21 | 2014-12-09 | Microsoft Corporation | Using external memory devices to improve system performance |
| US9317209B2 (en) | 2004-10-21 | 2016-04-19 | Microsoft Technology Licensing, Llc | Using external memory devices to improve system performance |
| US9529716B2 (en) | 2005-12-16 | 2016-12-27 | Microsoft Technology Licensing, Llc | Optimizing write and wear performance for a memory |
| US9361183B2 (en) | 2008-09-19 | 2016-06-07 | Microsoft Technology Licensing, Llc | Aggregation of write traffic to a data store |
| US9448890B2 (en) | 2008-09-19 | 2016-09-20 | Microsoft Technology Licensing, Llc | Aggregation of write traffic to a data store |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63152559U (en) | 1988-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5501949A (en) | Particle bound binding component immunoassay | |
| EP0138826B1 (en) | Detection of human chorionic gonadotropin | |
| US6403383B1 (en) | Diagnostic test kit for immunological assays of fluid samples | |
| US5236826A (en) | Immunoassay for the detection or quantitation of an analyte | |
| AU724089B2 (en) | Sensor laminates and multi-sectioned fluid delivery devices for detecting by immunoassay target molecules in biological fluids | |
| CA2599625C (en) | Dual path immunoassay device | |
| JP2628792B2 (en) | Improved ligand assays | |
| NO853050L (en) | DEVICE FOR CHEMICAL ANALYSIS AND APPLICATION THEREOF | |
| US6265176B1 (en) | Dot immunoassay on plastic sheets | |
| US7347972B1 (en) | Multiple analyte assay device | |
| US4615983A (en) | Immunological measuring element | |
| JPH11506213A (en) | Equipment for collecting, testing and transporting body fluid samples | |
| CN112534039A (en) | Lateral flow immunoassay device with separation membrane | |
| EP0270569A1 (en) | Cell detection system and method | |
| JP2001525063A (en) | Analyzers for membrane-based assays | |
| GB2342443A (en) | Immunoassay device | |
| CA2137786A1 (en) | Immunoassay | |
| JPH0239256Y2 (en) | ||
| US6432358B2 (en) | Diagnostic assay device | |
| EP0096050B1 (en) | Diagnostic test method | |
| US20070128072A1 (en) | Multiple analyte assay device | |
| JP4343406B2 (en) | Inspection kit | |
| CN210604659U (en) | Film developing device for chemiluminescence immunoassay | |
| JPH0569679U (en) | Specific protein detection container | |
| Jarvis | The future outlook for enzyme immunoassays |